Atlas Trials

A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS

Clinical trial NCT04400786 · UNKNOWN

Trial details

NCT number
NCT04400786
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Ankylosing SpondylitisTherapeutic Agent Toxicity
Start date
2020-05-07
Primary completion
2021-12-31
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.